The MediChain ICO is possibly the most exciting ICO yet launched with ambitions and aims far exceeding other earlier ones.

Like some other, MediChain stores medical data to allow patients to take control of and transfer data between providers, over time and even across geographic regions.

What distinguishes MediChain from other medical blockchains?

But there the superficial similarity ends as MediChain is the only system designed by people with experience in big data on this scale, pharmaceutical drug development and medical research over a number of key fields.

That means that unlike other solutions, which are essentially just blockchain adapted Electronic Health Record solutions, MediChain is a powerful blockchain big data solution by design.

This is MediChain’s USP and in which there are eight areas of application of analytics which can improve healthcare: 1) predictive modelling for risk and resource use; 2) population management; 3) drug and medical device safety surveillance; 4) disease and treatment heterogeneity; 5) precision medicine and clinical decision support; 6) quality of care and performance measurement; 7) public health; and 8) research applications. Predictive analytics using big data technology is technology that learns from experience (data) to predict the future behavior of individuals in order to drive better decisions (i.e., future insights), based on a full picture of associations, for example, across time or a wide geographic area, or observed in a substantial fraction of entire population.

These benefits not only help patients worldwide but make MediChain a natural partner to #ehr and #emr providers rather than a rival in a crowded and highly established market.

One of the great limits to using blockchain in medical data applications is speed. While systems like Visa card processing handle 24,000 transactions each second, Ethereum can only handle 20 transactions per second. Even the innovative Ripple can only handle 1,500 transactions each second. To overcome this, #MediChain are working on a patent-pending system designed by Mark Baker to allow parallel processing of the medical blockchain, to speed transactions up to a theoretical increase of 14,400 times with the data planned. MediChain’s approach may allow the speed that will outpace even state-of-the-art systems like Visa — but for medical data.

The MediChain data project has been in talks with national level medical projects and specialist departments all over the world including Rheumatology, Alzheimer’s, Epilepsy, as well as a major provider of Electronic Records Systems and major research institutes in · Heart Disease, Alzheimer’s Disease, Blindness, Arthritis and Cystic Fibrosis.

We have received strong feedback from hospitals and pharmaceutical companies already wanting to partner with us. This includes a definite from the Swisher Memorial Hospital and a number of other medical institutions in the pipeline, such as Cerner, AstraZeneca, Swiss SOS registry, CSIRO. What’s more, Wolfram Alpha have already said that would allow us use the Wolfram engine to do machine learning / AI to make automated medical decision making based on data stored within the database.

We expect to announce over a dozen collaborative big data programmes with major institutions from Q2 2018 onwards.

https://t.me/medichainonline_group